Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20190624043993N1Phase 2Completed
Phase 2, double-blind trial of heparin in decubitus ulcer (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoint: Wound characteristics over time at day 30. Started Jul 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20190624043993N1.